AIMS: Cervical Cancer (CC) is one of the most important health problems in women. It frequently presents genetic changes at chromosome region 3q21. This region contains the Cellular Retinol Binding Protein 1 gene (CRBP1) which has been implicated as an important element in the development of other types of cancer. The main goal of the present work was to determine the molecular alterations of CRBP1 and its relationship to CC. METHODS: To determine the molecular alterations of CRBP1 gene in CC; twenty-six CC and twenty-six healthy cervix samples were evaluated for: 1) Copy number gain by real-time PCR analysis, 2) expression levels by an immunohistochemistry assay on tissue microarray, and 3) the methylation status of the CRBP1 promoter region. RESULTS: The increase in CRBP1 copy number was observed in 10 out of the 26 CC samples analyzed, while healthy cervices samples showed no changes in the copy number. In addition, there was a lack of expression of the CRBP1 gene in an important number of the CC samples (17/26), and the CRBP1 gene promoter was methylated in 15/26 of the CC samples. Interestingly, there was a significant association between the lack of expression of the CRBP1 gene and its methylation status. CONCLUSIONS: The data indicates that, both activating and inactivating changes in the CRBP1 gene could be significant events in the development and progression of CC, and the lack of expression of the CRBP1 protein could be related with to the development of CC. We believe that there is enough evidence to consider to CRBP1 gene as a tumor suppressor gene for CC.
AIMS: Cervical Cancer (CC) is one of the most important health problems in women. It frequently presents genetic changes at chromosome region 3q21. This region contains the Cellular Retinol Binding Protein 1 gene (CRBP1) which has been implicated as an important element in the development of other types of cancer. The main goal of the present work was to determine the molecular alterations of CRBP1 and its relationship to CC. METHODS: To determine the molecular alterations of CRBP1 gene in CC; twenty-six CC and twenty-six healthy cervix samples were evaluated for: 1) Copy number gain by real-time PCR analysis, 2) expression levels by an immunohistochemistry assay on tissue microarray, and 3) the methylation status of the CRBP1 promoter region. RESULTS: The increase in CRBP1 copy number was observed in 10 out of the 26 CC samples analyzed, while healthy cervices samples showed no changes in the copy number. In addition, there was a lack of expression of the CRBP1 gene in an important number of the CC samples (17/26), and the CRBP1 gene promoter was methylated in 15/26 of the CC samples. Interestingly, there was a significant association between the lack of expression of the CRBP1 gene and its methylation status. CONCLUSIONS: The data indicates that, both activating and inactivating changes in the CRBP1 gene could be significant events in the development and progression of CC, and the lack of expression of the CRBP1 protein could be related with to the development of CC. We believe that there is enough evidence to consider to CRBP1 gene as a tumor suppressor gene for CC.
Authors: Manel Esteller; Mingzhou Guo; Victor Moreno; Miquel Angel Peinado; Gabriel Capella; Oliver Galm; Stephen B Baylin; James G Herman Journal: Cancer Res Date: 2002-10-15 Impact factor: 12.701
Authors: J R Caceres-Cortes; J A Alvarado-Moreno; K Waga; R Rangel-Corona; A Monroy-Garcia; L Rocha-Zavaleta; J Urdiales-Ramos; B Weiss-Steider; A Haman; P Hugo; R Brousseau; T Hoang Journal: Cancer Res Date: 2001-08-15 Impact factor: 12.701
Authors: Pulivarthi H Rao; Hugo Arias-Pulido; Xin-Yan Lu; Charles P Harris; Hernan Vargas; Fang F Zhang; Gopeshwar Narayan; Achim Schneider; Mary Beth Terry; Vundavalli V V S Murty Journal: BMC Cancer Date: 2004-02-06 Impact factor: 4.430
Authors: Keely Pierzchalski; Robert N Taylor; Ceana Nezhat; Jace W Jones; Joseph L Napoli; Guixiang Yang; Maureen A Kane; Neil Sidell Journal: Biol Reprod Date: 2014-08-20 Impact factor: 4.285
Authors: Elena Doldo; Gaetana Costanza; Sara Agostinelli; Chiara Tarquini; Amedeo Ferlosio; Gaetano Arcuri; Daniela Passeri; Maria Giovanna Scioli; Augusto Orlandi Journal: Biomed Res Int Date: 2015-03-24 Impact factor: 3.411
Authors: Ana L Arellano-Ortiz; Mauricio Salcedo-Vargas; Claudia L Vargas-Requena; José A López-Díaz; Antonio De la Mora-Covarrubias; Juan C Silva-Espinoza; Florinda Jiménez-Vega Journal: Genet Epigenet Date: 2016-11-10
Authors: K Yokoi; K Yamashita; S Ishii; T Tanaka; N Nishizawa; A Tsutsui; H Miura; H Katoh; T Yamanashi; M Naito; T Sato; T Nakamura; M Watanabe Journal: Br J Cancer Date: 2017-03-14 Impact factor: 7.640
Authors: Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Malayannan Subramaniam; John R Hawse; Kevin S Pitel; Hugo Arreola-De la Cruz; Victor Huerta-Padilla; Gustavo Ponce-Navarrete; Ma Del Pilar Figueroa-Corona; Laura Gomez-Virgilio; Teresa I Martinez-Cuevas; Monica Mendoza-Rodriguez; Miriam Rodriguez-Esquivel; Pablo Romero-Morelos; Jorge Ramirez-Salcedo; Michael Baudis; Marco Meraz-Rios; Florinda Jimenez-Vega; Mauricio Salcedo Journal: Sci Rep Date: 2018-06-21 Impact factor: 4.379